Takabe K - Search Results

1

The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer.

Li J, Zhang D, Liu Z, Wang Y, Li X, Wang Z, Liang G, Yuan X, Li Y, Komorowski AL, Rozen WM, Orlandi A, Takabe K, Franceschini G, Jerusalem G, Wang X. Li J, et al. Among authors: takabe k. Ann Transl Med. 2023 Jan 31;11(2):83. doi: 10.21037/atm-22-6446. Ann Transl Med. 2023. PMID: 36819490 Free PMC article.

2

Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial.

Yan M, Ouyang Q, Sun T, Niu L, Yang J, Li L, Song Y, Hao C, Chen Z, Orlandi A, Ishii N, Takabe K, Franceschini G, Ricci F, Verschraegen C, Liu Z, Zhang M, Lv H, Liu L, Yang X, Xiao H, Gao Z, Li X, Dong F, Chen X, Qiao J, Zhang G. Yan M, et al. Among authors: takabe k. Lancet Oncol. 2022 Mar;23(3):353-361. doi: 10.1016/S1470-2045(21)00716-6. Epub 2022 Jan 31. Lancet Oncol. 2022. PMID: 35085506 Clinical Trial.

3

A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer.

Gong C, Cheng Z, Yang Y, Shen J, Zhu Y, Ling L, Lin W, Yu Z, Li Z, Tan W, Zheng C, Zheng W, Zhong J, Zhang X, Zeng Y, Liu Q, Huang RS, Komorowski AL, Yang ES, Bertucci F, Ricci F, Orlandi A, Franceschini G, Takabe K, Klimberg S, Ishii N, Toss A, Tan MP, Cherian MA, Song E. Gong C, et al. Among authors: takabe k. Sci China Life Sci. 2022 Nov;65(11):2205-2217. doi: 10.1007/s11427-022-2104-3. Epub 2022 May 13. Sci China Life Sci. 2022. PMID: 35579777

4

Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer.

Wu R, Oshi M, Asaoka M, Yan L, Benesch MGK, Khoury T, Nagahashi M, Miyoshi Y, Endo I, Ishikawa T, Takabe K. Wu R, et al. Among authors: takabe k. Ann Surg. 2023 Oct 1;278(4):587-597. doi: 10.1097/SLA.0000000000005954. Epub 2023 Jun 15. Ann Surg. 2023. PMID: 37318852 Free PMC article.

5

Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.

Maiti A, Takabe K, Hait NC. Maiti A, et al. Among authors: takabe k. Cell Signal. 2017 Apr;32:85-92. doi: 10.1016/j.cellsig.2017.01.021. Epub 2017 Jan 17. Cell Signal. 2017. PMID: 28108260 Free PMC article.

6

Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.

Narayanan S, Kawaguchi T, Yan L, Peng X, Qi Q, Takabe K. Narayanan S, et al. Among authors: takabe k. Ann Surg Oncol. 2018 Aug;25(8):2323-2331. doi: 10.1245/s10434-018-6506-6. Epub 2018 May 16. Ann Surg Oncol. 2018. PMID: 29770915 Free PMC article.

7

Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.

Okano M, Oshi M, Butash AL, Katsuta E, Tachibana K, Saito K, Okayama H, Peng X, Yan L, Kono K, Ohtake T, Takabe K. Okano M, et al. Among authors: takabe k. Int J Mol Sci. 2019 Aug 27;20(17):4197. doi: 10.3390/ijms20174197. Int J Mol Sci. 2019. PMID: 31461932 Free PMC article.

8

High expression of polo-like kinase 1 is associated with TP53 inactivation, DNA repair deficiency, and worse prognosis in ER positive Her2 negative breast cancer.

Takeshita T, Asaoka M, Katsuta E, Photiadis SJ, Narayanan S, Yan L, Takabe K. Takeshita T, et al. Among authors: takabe k. Am J Transl Res. 2019 Oct 15;11(10):6507-6521. eCollection 2019. Am J Transl Res. 2019. PMID: 31737202 Free PMC article.

9

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer.

Katsuta E, Yan L, Takeshita T, McDonald KA, Dasgupta S, Opyrchal M, Takabe K. Katsuta E, et al. Among authors: takabe k. Int J Mol Sci. 2019 Dec 28;21(1):217. doi: 10.3390/ijms21010217. Int J Mol Sci. 2019. PMID: 31905596 Free PMC article.

10

KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.

Tokumaru Y, Oshi M, Katsuta E, Yan L, Satyananda V, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. Tokumaru Y, et al. Among authors: takabe k. Am J Cancer Res. 2020 Mar 1;10(3):897-907. eCollection 2020. Am J Cancer Res. 2020. PMID: 32266098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

451 results

Search Page